Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis

Inclusion Criteria: * Subjects of either gender, any race and between the ages of 18 and 70 inclusive * Subjects with a clinical diagnosis with culture confirmation of distal subungual onychomycosis (DSO) - Subjects must be free of any disease that in the Investigator's opinion might interfere with the study evaluations or jeopardize the subject's safety Exclusion Criteria: * Subjects with a history of intolerance or hypersensitivity to imidazole compounds or the inactive components of the solution * Subjects who are currently participating or have recently participated in another investigational medication or device study